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RESEARCH NOTE
One consensual depression diagnosis 
tool to serve many countries: a challenge! A 
RAND/UCLA methodology
P. Nabbe1* , J. Y. Le Reste1, M. Guillou‑Landreat2, E. Beck‑Robert1, R. Assenova3, D. Lazic4, S. Czachowski5, 
S. Stojanović‑Špehar6, M. Hasanagic7, H. Lingner8, A. Clavería9, M. I. Fernandez San Martin10, A. Sowinska11, 
S. Argyriadou12, C. Lygidakis13, B. Le Floch1, C. Doerr14, T. Montier15, H. Van Marwijk16 and P. Van Royen17
Abstract 
Objective: From a systematic literature review (SLR), it became clear that a consensually validated tool was needed 
by European General Practitioner (GP) researchers in order to allow multi‑centred collaborative research, in daily 
practice, throughout Europe. Which diagnostic tool for depression, validated against psychiatric examination accord‑
ing to the DSM, would GPs select as the best for use in clinical research, taking into account the combination of 
effectiveness, reliability and ergonomics? A RAND/UCLA, which combines the qualities of the Delphi process and of 
the nominal group, was used. GP researchers from different European countries were selected. The SLR extracted tools 
were validated against the DSM. The Youden index was used as an effectiveness criterion and Cronbach’s alpha as a 
reliability criterion. Ergonomics data were extracted from the literature. Ergonomics were tested face‑to‑face.
Results: The SLR extracted 7 tools. Two instruments were considered sufficiently effective and reliable for use: the 
Hospital Anxiety and Depression Scale and the Hopkins Symptoms Checklist‑25 (HSCL‑25). After testing face‑to‑face, 
HSCL‑25 was selected. A multicultural consensus on one diagnostic tool for depression was obtained for the HSCL‑25. 
This tool will provide the opportunity to select homogeneous populations for European collaborative research in daily 
practice.
Keywords: RAND/UCLA appropriateness method, Multicultural consensus, Delphi procedure, Depression diagnosis 
tool
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Introduction
Primary care is a strategic place for depression diagnosis 
and treatment [1–5]. This led to a triple challenge:
  • Improve early diagnosis.
  • Provide a simple and effective diagnostic tool that 
allows medical research in daily practice.
  • Gain consensus on the tool’s use irrespective of 
nationality.
For medical research, there are common selection cri-
teria: efficiency, reliability and ergonomics. The tool must 
be consensually accepted by researchers and have face 
validity. It must be validated to indicate when psychiatric 
referral is required and should be accepted by both psy-
chiatrists and General Practitioners (GPs) [6, 7]. Under 
the auspices of the European General Practice Research 
Network (EGPRN), European GP researchers decided to 
find such a tool. Experts representing different cultures, 
languages and health systems sought consensus [6, 8].
Seven tools were found using a systematic literature 
review. They needed to be validated against a psychiatric 
examination using the DSM’s major depression criteria, 
usable in primary care research and conceptually under-
standable by GPs and psychiatrists [9]. Consequently, this 
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method of selection excluded tools such as PHQ, which 
are not validated against the DSM [10]. Then it was nec-
essary to select the more reliable, efficient and ergonomic 
tool.
Based on these criteria, the research question was: 
which diagnostic tool for depression would GP research-
ers select as the most efficient, reliable and ergonomic for 




The psychometric properties, (sensitivity, specificity, 
positive and negative predictive values) of the tools were 
extracted [9]. They did not vary sufficiently to allow 
statistical comparison, as the study populations were 
different. Subsequently, a narrative review was under-
taken to extract the reliability data (Cronbach’s alpha, 
Cohen’s kappa). The ergonomics were also important, 
but comparing this aspect of tools was complex due to 
the number of items, test duration, method of inquiry, 
score range, etc. A consensus, taking into account quan-
titative and qualitative criteria, based on an European 
expert panel, was the only alternative to ensure com-
parison [11].
Consensus procedure
The RAND/UCLA appropriateness method (RAM) is 
approved by major institutes, such as the NICE (National 
Institute for health and Clinical Excellence) in the United 
Kingdom or the HAS (Haute Autorité de Santé) in 
France. It was the most appropriate consensus method 
[12, 13].
Developed in the mid-1980s, it is an instrument to 
enable the measurement of the overuse and underuse of 
medical and surgical procedures. It allows a consensual 
choice in the comparison of complex processes [11].
RAND/UCLA is a “two-round modified Delphi pro-
cess” which includes a nominal group. The Delphi rounds 
avoid leader opinion influence; the panel meeting creates 
the opportunity to discuss ratings and judgments face to 
face [14] (Fig 1).
Based on the result of a narrative review completed ini-
tially, the quality level of the RAM is increased when the 
results of a systematic review are used [11, 14].
The RAM is one of several methods that was devel-
oped to identify the collective opinion of experts [11]. 
With RAM, repeated assessment is used by all experts 
to rank relevance, objectivity and homogeneity [13]. 
The RAM produces appropriateness criteria and qual-
ity indicators with face, construct and predictive valid-
ity [15].
Experts’ panel
The experts’ panel was purposively selected from primary 
care, on research expertise, academic expertise, English 
level, gender, practice, native culture and language [16].
First step
The study started with a Delphi procedure to elimi-
nate the less efficient and keep the more reliable tools. 
The comments took into account only validity data, not 
ergonomics.
Each expert received the study flow-chart; study 
method; efficiency, sample and reliability data and con-
sent form. They had to rate the efficiency and reliability 
of each tool on a 9-point Likert scale [17]:
  • Is this tool efficient for the diagnosis of depression in 
primary care?
  • Is this tool reliable for the diagnosis of depression in 
primary care?
Consensus was defined as at least 70% of the experts 
rating questions at 7 or above [13]. A tool was considered 
appropriate if it scored higher than 70% on each ques-
tion. Comments were collected in order to structure the 
experts’ panel meeting.
Second step
The 2nd step (panel meeting) had to confirm the results 
of the 1st step and allow debate, without voting, result-
ing in a presentation of the selected tools. The follow-
ing resources were provided to experts: methodology 
reminder, first-round results including all comments, 
ergonomic features, bibliography data and three 9-point 
Likert scale notation forms. The forms were completed at 
the beginning, after testing tools, and at the end of the 
experts’ meeting.
The experts were invited to discuss the results of the 
first round and whether they agreed with them. If more 
than 70% of the experts agreed with the results, the first 
Delphi round was considered successful.
The experts were invited to rate the following 
statements:
  • “This tool is easy to use in general practice”.
  • “This tool could easily be introduced during a consul-
tation”.
  • “This tool could be understood by patients”.
  • “I like this tool”.
  • “Patients could be surprised by this tool”.
Experts were invited to evaluate before and after test-
ing the tools face-to-face in pairs. This was undertaken 
Page 3 of 8Nabbe et al. BMC Res Notes  (2018) 11:4 
to assess whether testing tools had modified their judg-
ment. Then the ergonomics were discussed. The meet-
ing ended with final evaluations. The entire meeting was 
recorded in both video and audio format for ultimate 
quality control.
No final consensus was required at the end of the meet-
ing [11].
Third step
The goal was to select one tool. At the end of the experts’ 
meeting, all discussions were transcribed. Each expert 
received the transcript independently.
The final question was: “Which is the most appropri-
ate tool for the diagnosis of depression in adult patients, 
in General Practice, in Europe, in terms of Efficiency, 
Reproducibility and Ergonomics?” The experts were 
asked to vote on each tool and to comment on their 
responses.
Results
Eleven experts from 8 European countries participated. 
They were all GPs, fluent in English. The panel was com-
posed of 9 women and 2 men. Of the 11 experts, 9 prac-
tised in urban areas of more than 5000 inhabitants and 
Fig. 1 The RAM flow: descriptive diagram of the entire consensus procedure by RAND/UCLA or RAM
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2 worked in urban areas with 2000–5000 inhabitants 
(Table 1).
The tools selected by the literature review were: GDS-
5, 15 and 30 (Geriatric Depression Scale with 5, 15 and 
30 items), the HSCL-25 (Hopkins Symptoms Checklist 
with 25 items), the HADS (Hospital Anxiety Depression 
Scale), the PSC-51 (physical symptom checklist in 51 
items), and the CES-DR (Center for Epidemiologic Stud-
ies Depression Scale-Revised).
First step results
The PSC-51, GDS-30 and CES-DR: eliminated for lack of 
efficiency.
The GDS-15 and GDS-5: eliminated for lack of 
reliability.
The HADS and the HSCL-25: considered efficient and 
reliable (Table 2).
Second step results
Eight experts participated and confirmed that HSCL-25 
and HADS were the best-validated tools in terms of effi-
ciency and reliability.
Before the ergonomics test, the experts had favoured 
HADS. Their individual opinions were modified after 
testing the HSCL-25 face-to-face (Table  3). Consensus 
was not sought at the end of the meeting.
Table 1 Expert panel-participants’ characteristics
* PubMed database










8 F Bosnia Teacher/ 2000–5000 GP group office 2 22 12
Researcher
10 F Bulgaria Teacher/ > 5000 GP group office 9 14 12
Researcher
7 F Croatia Teacher/ > 5000 Alone 6 20 12
Researcher
9 F Croatia Teacher/ > 5000 GP group office 18 30 20
Researcher
5 F Germany Researcher 2000–5000 Stopped practising 
2 years earlier
19 23 5
11 F Germany Researcher > 5000 GP group office 4 18 7




4 M Italy Researcher > 5000 GP group office 23 7 6
6 M Poland Teacher/ > 5000 GP group office 20 30 12
Researcher
2 F Spain (Cataluña) Teacher/ > 5000 GP group office 13 22 25
Researcher
1 F Spain (Galicia) Teacher/ > 5000 GP group office 15 20 14
Researcher




Scores > 6 as percentage Median (average) Scores > 6 as percentage 
PSC 51 5 (5) 0 7 (6.9) 80 Eliminated tools: reliable but not efficient
GDS 30 4 (3.6) 0 7 (7.3) 90
CES DR 4 (3.8) 0 8 (8.1) 90
GDS 15 8 (7.7) 100 6 (6.6) 0 Eliminated tools: efficient but not reliable
GDS 5 7 (7.4) 91 2 (1.8) 0
HADS 7 (7.2) 91 7 (7.4) 100 Selected tools: considered both efficient 
and reliableHSCL 25 7.5 (7.3) 82 9 (8.5) 100
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All comments were collected and were returned to the 
experts in the document they were sent for the 3rd phase 
(for example):
HADS: The questions are difficult for patients to 
understand; the answers are difficult for patients 
because they correspond to positive and negative 
choices; this tool is too long.
HSCL-25: The answers are on a 1 to 4 Likert scale; 
the responses are recorded by checking on a table; 
the answers are simpler.
Third step results
The 8 experts who participated in the whole procedure 
were asked to vote:
“Which is the most appropriate tool to diagnose 
depression in adult patients in General Practice, in 
Europe, in terms of its efficiency, its reliability and its 
ease of use?”
  • 6 answered, “In my opinion, the HSCL-25 is the most 
appropriate tool to diagnose depression in Primary 
Care practice.”
  • 2 answered, “In my opinion, the HADS is the most 
appropriate tool to diagnose depression in Primary 
Care practice.”
The experts gave final comments (for example):
“After analysing all the psychometric properties, the 
most useful test in primary care in many countries 
in Europe, with numerous cultural variations, is the 
HSCL-25.”
“In terms of effectiveness, reliability and ergonomics, 
the HSCL-25 is my first choice. However, I must add 
that the HADS is the best-known and most com-
monly applied tool in clinical practice, as well as in 
scientific discussions between different medical and 
non-medical professionals. In communication and 
discussion with our colleagues, it is crucial for the 
monitoring of depressed patients; we have to think 
about this if we choose the HSCL-25.”
“The HSCL-25: Simple, detailed enough for the 
diagnosis, short administration time, easy to under-
stand.”
Discussion
The HSCL-25 appeared the most interesting tool for 
diagnosing depression in terms of the combination of its 
efficiency, reliability and ergonomics. It is a self-rating 
scale derived from the SCL-90 which is a multidimen-
sional psychological test instrument for the assessment 
of psychological symptoms and distress [18–20]. It has 
robust efficiency and reliability scores [21–23].
This RAM study was based on a systematic literature 
review [9], of higher quality than the original RAM with 
a non-systematic literature review. The ergonomic factor 
was an important criterion in maintaining a relationship 
between patients and GPs. Researchers demonstrated by 
this process how ergonomics were decisive in choosing a 
tool suitable for future research [24].
HSCL 25 has been widely used for evaluation among 
traumatised populations and used many times in primary 
care [25–29]. HADS has been widely used over a long 
period for clinical and research purposes [30]; has been 
Table 3 Evaluation progression during the experts’ meeting
Tools Statements put to the experts Scores > 6 as percentage on a 9-point Likert scale
First evaluation: 
after reading only usable 
data
Second evaluation: after test-




among all the experts
HADS This tool is easy to use in GP’s practice 50 12.5 12.5
This tool could easily be introduced during a 
consultation
25 12.5 12.5
This tool could be understood by patients 37.5 12.5 12.5
I like this tool 25 12.5 12.5
Patients could be surprised by this tool 75 62.5 62.5
HSCL‑25 This tool is easy to use in GP’s practice 87.5 100 100
This tool could easily be introduced during a 
consultation
87.5 75 75
This tool could be understood by patients 87.5 62.5 75
I like this tool 87.5 87.5 87.5
Patients could be surprised by this tool 25 0 0
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translated into several languages [31] and validated for 
use in primary care. Nevertheless, HADS seemed com-
plicated for research purposes in daily practice [32–34].
The PSC-51, the CES-DR [35] and the GDS (GDS-30) 
were considered but efficiency was too low. The GDS 
was developed specifically to detect depression in elderly 
patients [36]. It was rejected in the 2 shorter versions: 
GDS-15 and GDS-5 as reliability was too low [37–41].
In conclusion, the HSCL-25 best combined efficiency, 
reliability and ergonomics for diagnosis of depression 
within European primary care practice from a research 
perspective. It will allow multi-centred collaborative 
research throughout Europe. HSCL-25 could allow trans-
versal research between psychiatrists and GPs. The group 
will be vigilant as a self-administered questionnaire 
must be easily understood by the general population. Its 
translation into several European languages allows col-
laborative research. Application in practice must be dem-
onstrated for each national translation.
Limitations
The quality of the panel was important for the overall 
quality level. The panel conformed to the requirements 
of variability in culture, language and practice. 4 language 
families were represented: Germanic, Slavic, Hellenic and 
Romance. The panel size was sufficient (7–15 experts) 
[11].The deadlines for the Delphi rounds were short. Each 
judgment was performed blind [42]. To reduce informa-
tion bias, each expert received a record of all the biblio-
graphic sources of the data provided.
The reliability data were mainly based on Cronbach’s 
alpha values. Those values were extracted using an addi-
tional literature review [43].
The tools found in literature were not anonymised. 
The judgment of each expert could possibly take his/
her knowledge into account. Nevertheless, the experts’ 
opportunity for debate during meetings controlled this 
possible confusion bias.
A systematic literature review creates the possibility of 
original selection bias. From the outset, the gold stand-
ard was the psychiatric examination based on the DSM’s 
major depression criteria. Tools with a high level of valid-
ity but which did not use this gold standard as their start-
ing point, such as PHQ [44], could not be selected. The 
objective of the SRL was to focus on the tools; the list was 
not exhaustive. It could be worthwhile to initiate a study 
using another gold standard, such as the Hamilton test 
[45], and compare results.
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